Literature DB >> 24904184

Utilization of Pharmacist Responders as a Component of a Multidisciplinary Sepsis Bundle.

Jeremy D Flynn1, Kevin W McConeghy2, Alexander H Flannery3, Melissa Nestor4, Pam Branson3, Kevin W Hatton3.   

Abstract

BACKGROUND: Sepsis and septic shock remain a significant burden on the US health care system. A multidisciplinary response system (Coordinated Response to Sepsis, CaRTS) that included a pharmacist responder was implemented for patients with newly suspected sepsis.
OBJECTIVE: To evaluate the time to appropriate antibiotic administration among patients with the CaRTS intervention compared with historical controls.
METHOD: The CaRTS intervention included an electronic order set as well as activation of a multidisciplinary team of pharmacy and nursing personnel to coordinate resuscitation and medication administration. The CaRTS group was compared to historical controls. The primary outcome of the study was the proportion of patients with appropriate antibiotic administration within 1 hour of recognition of sepsis. Secondary outcomes included achievement of mean arterial pressure (MAP) ≥65 mm Hg and central venous pressure (CVP) of 8 to 12 mm Hg within 6 hours. RESULT: The CaRTS intervention was used for 49 patients and 59 historical controls were included for analysis. Patients with the CaRTS intervention had a greater than 20 times higher odds of antibiotic administration within 1 hour compared with controls (odds ratio [OR] 22.4, 95% confidence interval [CI] 7.5-69) and were more likely to have a CVP ≥8 mm Hg at 6 hours (OR 2.4, 95% CI 1.0-5.6) compared with controls. CaRTS patients achieved statistically nonsignificant increases in MAP ≥65 mm Hg (OR 2.2, 95% CI 0.7-7.7).
CONCLUSION: Utilization of a multidisciplinary sepsis bundle that included a pharmacist responder improved the proportion of patients receiving appropriate antibiotics within 1 hour of recognition of sepsis compared to historical controls.
© The Author(s) 2014.

Entities:  

Keywords:  bundle; pharmacist; sepsis; septic shock

Year:  2014        PMID: 24904184      PMCID: PMC4376659          DOI: 10.1177/1060028014538773

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  15 in total

1.  Time to effective antibiotic administration in adult patients with septic shock: a descriptive analysis.

Authors:  Zahra Kanji; Carla Dumaresque
Journal:  Intensive Crit Care Nurs       Date:  2012-04-24       Impact factor: 3.072

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  Before-after study of a standardized hospital order set for the management of septic shock.

Authors:  Scott T Micek; Nareg Roubinian; Tim Heuring; Meghan Bode; Jennifer Williams; Courtney Harrison; Theresa Murphy; Donna Prentice; Brent E Ruoff; Marin H Kollef
Journal:  Crit Care Med       Date:  2006-11       Impact factor: 7.598

4.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

5.  The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis.

Authors:  Mitchell M Levy; R Phillip Dellinger; Sean R Townsend; Walter T Linde-Zwirble; John C Marshall; Julian Bion; Christa Schorr; Antonio Artigas; Graham Ramsay; Richard Beale; Margaret M Parker; Herwig Gerlach; Konrad Reinhart; Eliezer Silva; Maurene Harvey; Susan Regan; Derek C Angus
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

6.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; R Moreno; J Takala; S Willatts; A De Mendonça; H Bruining; C K Reinhart; P M Suter; L G Thijs
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

7.  Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program.

Authors:  Ricard Ferrer; Ignacio Martin-Loeches; Gary Phillips; Tiffany M Osborn; Sean Townsend; R Phillip Dellinger; Antonio Artigas; Christa Schorr; Mitchell M Levy
Journal:  Crit Care Med       Date:  2014-08       Impact factor: 7.598

8.  Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality.

Authors:  H Bryant Nguyen; Stephen W Corbett; Robert Steele; Jim Banta; Robin T Clark; Sean R Hayes; Jeremy Edwards; Thomas W Cho; William A Wittlake
Journal:  Crit Care Med       Date:  2007-04       Impact factor: 7.598

9.  Timing of appropriate antibiotics in patients with septic shock: a retrospective cohort study.

Authors:  Martin Cullen; Toby Fogg; Anthony Delaney
Journal:  Emerg Med Australas       Date:  2013-07-21       Impact factor: 2.151

10.  Multicenter implementation of a severe sepsis and septic shock treatment bundle.

Authors:  Russell R Miller; Li Dong; Nancy C Nelson; Samuel M Brown; Kathryn G Kuttler; Daniel R Probst; Todd L Allen; Terry P Clemmer
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

View more
  2 in total

1.  The Role of Clinical Pharmacists in the Emergency Department.

Authors:  Brenna M Farmer; Bryan D Hayes; Rama Rao; Natalija Farrell; Lewis Nelson
Journal:  J Med Toxicol       Date:  2017-10-26

2.  Importance of Pharmacy Involvement in the Treatment of Sepsis.

Authors:  Joseph B Cavanaugh; Jesse B Sullivan; Nicole East; Jessica N Nodzon
Journal:  Hosp Pharm       Date:  2017-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.